AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- Open
- $102.95
- 52-wk high
- $107.96
- High
- $105.11
- 52-wk low
- $61.23
- Low
- $102.39
- Prev close
- $106.12
Smart money
Earnings
Earnings came in 25.4% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $354.3M | $451.8M | $376.7M | $481.0M |
| Cost of what it sold | $73.0M | $102.1M | $108.8M | $79.2M |
| Gross profit | $281.3M | $349.6M | $268.0M | $401.8M |
| What it spent | ||||
| Research and development | $17.3M | $31.9M | $25.6M | $27.7M |
| Sales and admin | $46.1M | $77.0M | $57.9M | $57.0M |
| Other operating costs | — | -$13.7M | — | $29.5M |
| Total operating expenses | $63.3M | $95.2M | $83.4M | $114.2M |
| What was left | ||||
| Operating profit | $217.9M | $254.4M | $184.5M | $287.7M |
| Interest on debt | $4.3M | $4.9M | $5.5M | $5.6M |
| Profit before tax | $219.0M | -$100.8M | $180.3M | $284.9M |
| Tax | $43.7M | $40.7M | $30.3M | $55.0M |
| Net profit | $175.2M | -$141.6M | $150.0M | $229.9M |
| EBITDA | $243.7M | -$69.3M | $219.6M | $320.0M |
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
83overbought
20D volatility
69%annualized
52-week range
$61.23$107.96
20D support
News
What the news says
31 articles · 7 days
Coverage is bullish
Tone of tracked coverage
Wedge Capital Management L L P NC Invests $31.61 Million in Halozyme Therapeutics, Inc. $HALO
BullishAug 12Handelsbanken Fonder AB Grows Stake in Halozyme Therapeutics, Inc. $HALO
BullishAug 12Halozyme director Connaughton sells $167,152 in shares
Leans bullishAug 11